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School of Medicine, Springfield, IL 62794-9628
Abstract
Epidemiological studies suggest that estrogen therapy protects against clinical expression of
chronic neurological diseases. These beneficial effects of estrogen therapy are highly modified by
apolipoprotein E (apoE) through an unknown mechanism. We examined the short-term effects of
estradiol replacement in ovariectomized mice on apoE expression and markers for cell
proliferation, reactive gliosis, neuronal maturation, and synaptogenesis in the primary olfactory
pathway of wild-type (WT) and apoE knockout (KO) mice. Three days of estradiol replacement
increased apoE expression in the olfactory nerve and in the glomerular layer. Estradiol treatment
also increased cell proliferation, total cell numbers, number of mature neurons in the olfactory
epithelium, and reactive astrocyte numbers in the olfactory bulb (OB) in both WT and KO mice.
We also found that estradiol increased glomerular synaptophysin (Syn), but the magnitude of
increase was potentiated by the presence of apoE. This data suggest that apoE may be necessary to
elicit the complete effect of estradiol on Syn upregualtion.
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1. Introduction
Epidemiological studies suggest that estrogen therapy protects against clinical expression of
Alzheimer’s and Parkinson’s diseases (Henderson, 2005; Paganini-Hill and Henderson,
1994; Tang et al., 1996). However, prospective studies with estrogen neither slowed the
progression of dementia nor protected against cognitive decline in the Women’s Health
Initiative Memory study (Espeland et al., 2004; Shumaker et al., 2003).
Previous non-human studies have demonstrated that 17β-estradiol has numerous beneficial
effects on the brain, and many of these effects involve apolipoprotein E (Horsburgh et al.,
2002; Nathan et al., 2004; Stone et al., 1998; Struble et al., 2007; Teter et al., 1999). ApoE is
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a lipid transporting protein, and it ranges in length from 279 to 310 residues, with a high
degree of sequence conservation among species. The three common isoforms of apoE in
humans differ by amino acids at positions 112 and 158 (Weisgraber, 1994). The most
common isoform, apoE3, contains cysteine and arginine at positions 112 and 158,
respectively. Both positions contain cysteine in apoE2 and arginine in apoE4. Mice have one
form of apoE, which is similar to human apoE3 in its structural and functional properties,
including receptor binding and lipoprotein preferences (Weisgraber, 1994).
Estradiol replacement can increase apoE in rodent models (McAsey et al., 2006; Nathan et
al., 2004; Srivastava et al., 1997), and apoE has striking isoform-specific effects on the risk
for several neurological diseases including Alzheimer disease (AD), Parkinson disease, and
multiple sclerosis (Henderson, 2005; Paganini-Hill and Henderson, 1994; Tang et al., 1996).
Cross-sectional analyses have shown an interaction between estrogen therapy and apoE
genotype on learning and memory in postmenopausal women. Estrogen therapy improved
performance in episodic memory only in women with apoE3, but not in women with apoE4
(Burkhardt et al., 2004). Furthermore, estrogen therapy reduced cognitive decline, but only
in women who were not carriers for apoE4 allele (Yaffe et al., 2000).
ApoE allele status is also associated with olfactory dysfunction. ApoE4 carriers show a
significant decline in odor threshold and odor identification, and have delays in processing
of olfactory information (Bacon et al., 1998; Calhoun-Haney and Murphy, 2005; Gilbert and
Murphy, 2004; Murphy et al., 1998; O’Hara et al., 1998). To our knowledge, only one study
has looked at the effects of estradiol on the olfactory system repair, showing that estradiol
treatment resulted in significantly faster and better recovery of olfactory discrimination
performance following olfactory epithelium (OE) injury (Dhong et al., 1999). The
physiological basis underlying the beneficial effects of estradiol on olfactory function is not
clear. Therefore, we evaluated the effects of estradiol replacement on several parameters of
olfactory system integrity and compared the effects in normal mice to those lacking apoE.
We examined the acute effects of estradiol replacement following ovariectomy on
expression of apoE and markers for cell proliferation, reactive gliosis, neuronal maturation,
and synaptogenesis in the primary olfactory pathway in mice as a first step towards
understanding the role of estrogen in the olfactory system. The expressions of these
parameters were examined in wild-type (WT) and apoE knockout (KO) mice to understand
the impact of apoE deficiency on estradiol’s effect.
We found that estradiol replacement increased apoE expression in the olfactory nerve and in
the glomerular layer. Glial cells appear to be the primary producers of apoE. Estradiol
treatment increased OE thickness, basal cell proliferation, the density of mature neurons in
the OE, and astroglial numbers and synaptogenesis in the olfactory bulb (OB) in both WT
and KO mice. We also found that estradiol increased glomerular synaptophysin (Syn), but
the magnitude of increase was potentiated by the presence of apoE. This data suggest that
apoE may be necessary to elicit the complete effect of estradiol on Syn upregualtion.
2. Results
2.1. ApoE
ApoE immunostaining in both the estradiol- and vehicle-treated mice was intense at the
olfactory epithelial surface and in cytoplasmic processes of the sustentacular cells extending
to the epithelial surface. ApoE immunoreactive processes were present between the
olfactory sensory neuron (OSN) bundles in both the vehicle- and estradiol-treated groups;
however, a localization difference was apparent. The immunoreactive processes in the
estradiol-treated mice terminated on faintly stained globular structures above the unstained
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basal lamina. We previously showed that these globular structures expressed GBC-1, a
marker for globose basal cells (Nathan et al., 2007). In contrast, in the absence of estradiol,
apoE immunostaining was concentrated on oblong cells that were arranged on a plane
parallel to the unstained basal lamina. The morphology and location of these oblong cells
resemble horizontal basal cells, but this conclusion warrants further studies (Holbrook et al.,
1995).
The endothelial cells of blood vessels and cells surrounding the olfactory nerve in the lamina
propria were intensely stained for apoE in both vehicle- and estradiol-treated groups. ApoE
immunostaining was present throughout the core of the nerve bundles in estradiol-treated
mice. In contrast, only very faint apoE staining was observed in the vehicle-treated mice. In
essence, estradiol treatment slightly increased apoE expression in the olfactory nerve.
Estradiol treatment intensified apoE staining in the olfactory nerve and glomerular layers in
the OB. In the olfactory nerve of estradiol-treated mice, the large fascicles were consistently
stained, and were demarcated from each other by densely stained cellular processes.
Glomeruli were less intensely stained than the olfactory nerve and were clearly outlined by
immunostained cells in the septae surrounding the glomeruli as previously described
(Nathan et al., 2001; Struble et al., 1999). In the vehicle-treated mice apoE immunostaining
was weak throughout the OB.
2.2. GFAP
Astrocytes are the primary producers of apoE in the CNS (Pitas, 1987). Irrespective of the
apoE genotype, the density of glial fibrillary acidic protein (GFAP) immunoreactive
processes was increased by estradiol treatment compared to vehicle. Quantification of the
GFAP process density revealed that estradiol treatment significantly (F1,8=24.46; p<0.001)
increased process density in both the WT and KO mice. Neither genotype (F1,8=1.39. NS) or
the interaction between genotype and treatment (F1,8=0.049; NS) reached significance.
Estradiol replacement appeared to directly affect the expression of immunoreactive GFAP
irrespective of the presence of apoE.
2.3. OE thickness
Measures of OE thickness showed that estradiol replacement resulted in a thicker (28%) OE
compared to vehicle treated groups regardless of apoE genotype (F1,8=10.17; p<0.02).
Neither genotype (F1,8=0.62; NS) nor the interaction between genotype and treatment
(F1,8=0.17; NS) reached significance. ApoE presence or absence did not modulate the
estradiol effect on thickness.
2.4. BrdU
Estrogen treatment marginally increased BrdU staining in the OE of WT and KO mice,
although this did not reach standard levels of significance (F1,8=5.036; p<0.055) in both
genotypes. No other contrast approached significance.
2.5. OMP
Olfactory marker protein (OMP) is a marker for mature OSN in the OE. We found that WT
mice had about 20% more OMP labeled cells in the OE than the KO mice (F1,8=9.93;
p<0.014). Estradiol treatment increased (almost doubled) the density of OMP cells in the OE
as compared to vehicle (F1,8=71.46; p<0.001) regardless of genotype. We found no
interaction between treatment and genotype (F1,8=0.65; NS) indicating that the effects of
estradiol and genotype on OMP expression were independent. Estradiol treatment increased
OMP staining in the glomerular layer of both genotypes as compared to their respective
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vehicle group. As observed in the OE, OMP staining was more intense in the estradiol-
treated WT than in the estradiol treated KO mice.
2.6. Syn
Syn staining of glomeruli presented a complex picture with a significant interaction between
genotype and estradiol replacement (F1,8=84.17; p<0.001). Syn staining was more intense in
the vehicle-treated WT mice than in the vehicle-treated KO mice. Estradiol treatment
increased Syn immunoreactivity by about 19% in the KO mice to reach the level of the
vehicle-treated WT group. Estradiol replacement in WT mice increased Syn
immunoreactivity by 30%. In essence, the absence of apoE in KO mice was associated with
less Syn and an attenuated, but still significant increase in response to estradiol replacement.
3. Discussion
Two major differences in apoE staining pattern were observed in the OE of estradiol- versus
vehicle-treated groups. First, apoE staining in the olfactory fascicles of estradiol-treated
mice was diffuse, but consistently present. In contrast, in the vehicle-treated group, apoE
expression in the olfactory nerve was undetectable. Second, in the estradiol-treated group,
apoE staining above the basal lamina was weak and was punctuate around globular
structures. In a previous study we showed that these apoE-expressing punctae were the end
feet of sustentacular cells on globose basal cells (Nathan et al., 2007). In contrast, apoE was
concentrated in horizontal and flat cellular structures in the basal cell zone in the vehicle-
treated group. The distribution and morphology of these cells appears to be horizontal basal
cells (Holbrook et al., 1995).
We also found that estradiol replacement following ovariectomy increased apoE in the
olfactory nerve and in the glomerular layer of the OB. The distribution and morphology of
the cells contributing to this increased apoE production appear to be ensheathing glial cells
in the olfactory nerve and astroglial cells surrounding the glomeruli (Nathan et al., 2007).
Estradiol induced increase in apoE has been observed in various neural and non-neuronal
tissues (Nathan et al., 2004; Srivastava et al., 2001; Srivastava et al., 1996; Srivastava et al.,
1997; Stone et al., 1997; Wang et al., 2006).
Estradiol replacement was associated with substantial increase in GFAP process density in
the glomerular layer of WT mice. How estradiol increases GFAP process density is unclear;
however, previous studies have reported this phenomenon (Lewis et al., 2008; Ritz and
Hausmann, 2008). The presence of apoE is not critical for this process since estradiol
replacement in KO mice also resulted in a significant increase in GFAP process density. An
alternative explanation for the increase in process density is that estradiol simply increased
the expression and or the detection of GFAP, without affecting process growth. A previous
study has shown that estradiol affects the amount and or the distribution of GFAP in the
astrocyte, and there by increases GFAP staining intensity (Garcia-Segura et al., 1989).
Estradiol replacement was associated with increased epithelial thickness by about 28%, and
this effect was independent of apoE presence. The thickness increase could indicate an
increase in cell division. Several previous studies have shown that estradiol can increase
BrdU incorporation and cell counts (Barha et al., 2009; Pawluski et al., 2009). Estradiol can
indirectly increase basal cell proliferation by increasing signaling factors promoting basal
cell proliferation (Beites et al., 2005). The precise mechanism whereby estradiol increases
epithelial thickness is unclear; however, a partial explanation may be obtained from the
OMP data noted below.
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The OMP phenotype represents a “mature” OSN that has made contact with the post-
synaptic cells of the OB (Graziadei et al., 1980; Sydor et al., 1986). Hence, an estradiol
replacement-induced increase in the number of OMP+ OSN in the OE of both the WT and
KO mice suggests that estradiol replacement either maintained the adult population in
response to loss of ovarian hormones or estradiol facilitated OSN maturation. Estradiol
could also have facilitated OSN maturation by promoting synaptogenesis with the neurons
in the OB. Alternatively, estradiol induced increase in cell division could have contributed to
an increase in the OMP+ cell counts in the OE. However, this possibility is unlikely as
previous studies have shown that it takes at least 7 days for a newly generated cell in the OE
to transform into a mature OSN phenotype, and therefore, three days of estradiol is probably
not adequate (Graziadei and Graziadei, 1979). Hence, changes in BrdU may not be
significant at this stage after OVX.
We also found that the OMP cell density in OE and intensity of OMP staining in the OB was
greater in the WT than the KO suggesting an effect of apoE on OE maintenance. One
possible explanation for this difference is that cell genesis rates in KO and WT are
comparable but, as we have shown axonal growth and synaptogenesis following a lesion of
the OE are delayed in KO mice (Nathan et al., 2005; Nwosu et al., 2008). Hence, increased
OMP cell density in WT OE, regardless of estradiol replacement indicates that apoE
facilitates maturation of OSN to phenotypically adult cells.
An incomplete or aberrant status of synaptogenesis in the KO compared to the WT is
supported by Syn density. Overall, estradiol was associated with increased Syn but the
baseline level and magnitude of increase was suppressed by the absence of apoE. A decrease
in Syn staining has been shown in the hippocampus, neocortex, and OB of apoE KO mice
(Masliah et al., 1995; Nwosu et al., 2008). Our data parallel these previous studies and
present a possible mechanism to explain this. Specifically, normal regeneration may be
slightly delayed in apoE KO mice and this result in fewer synapses. Estradiol replacement
following ovariectomy can increase several synaptic proteins, including Syn perhaps by
stimulation of synaptic maturation. ApoE may be necessary to elicit the complete effect of
estradiol on Syn upregualtion.
Our data may be explained by hypothesizing two independent factors simultaneously
affecting the OE and OB, estradiol and apoE. Estradiol deprivation in ovariectomized mice
may lead to degeneration of the OE owing to the loss of trophic actions of estrogen. This
hypothesis is based on the following observations. First, degeneration of the OE in the
vehicle-replaced mice would explain the thinner OE as compared to estradiol-replaced mice.
Second, reduced OMP immunoreactivity in the OE of vehicle-replaced mice could represent
death of mature OSN in the OE. Third, decreased OMP staining in the glomerular layer of
the vehicle-replaced mice may be due to loss of mature axons of OSN in the glomeruli.
Finally, the distribution of apoE, from globose cells in the estradiol treated mice to
horizontal cells in the vehicle treated mice, may also represent OE degeneration. Horizontal
cells are multipotent precursor cells, as they are capable of producing the full complement of
cell types in the adult OE (Carter et al., 2004). Increased expression of apoE in the
horizontal cells of the vehicle-replaced mice may facilitate lipid recycling from degenerating
OSN to support rapid proliferation of horizontal cells, and their subsequent differentiation to
other OE cell types (Nathan et al., 2005).
OB changes in apoE immunoreactivity could represent a direct effect of estradiol on the
production of apoE as we have previously reported for the OB (McAsey et al., 2006; Struble
et al., 2003). The increase in apoE is associated with an increase in GFAP+ cells in the
estradiol treated mice. Since astrocytes are the chief producer of apoE in the nervous system,
it is possible that estradiol increased apoE production by increasing astrocyte numbers.
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Alternatively, estradiol’s effect on increasing apoE and GFAP are unrelated. Increase in
GFAP could represent either a direct effect of estradiol on GFAP expression/detection. Our
data suggest either of these scenarios is reasonable.
Finally, decreased OMP and Syn in apoE KO mice may represent fewer axons with adult
phenotypes in the KO than the WT. Lower OMP levels could also represent slower
synaptogenesis in the apoE KO mice combined with the effects of degenerating OSNs.
Hence, we would expect an interaction between genotype and conversion of remaining OSN
axons to the adult phenotype expressing OMP. To further clarify these issues of
degeneration following ovariectomy, a long-term study needs to be performed to determine
if the OE has reached asymptote. Interventions after asymptote would further clarify the role
of estradiol and the integrity of the OE following ovariectomy.
4. Materials and Methods
4.1. Animals
Breeding pairs of WT C57BL/6 strain and homozygous apoE KO mice were purchased from
the Jackson Laboratories, Bar Harbor, ME. ApoE genotype of the litters were verified by
PCR and confirmed by immunoblotting using anti-apoE as described below. Four months
old mice were used in this study.
4.2. Ovariectomy
WT and KO littermate mice, four months of age at the start of this study, were used. Mice
were ovariectomized (OVX) by a dorsal, bilateral approach under ketamine (100 mg/kg) and
xylazine (50 mg/kg) (Sigma, St. Louis, MO) anesthesia and sterile operating conditions. The
animals recuperated for five days prior to estradiol/vehicle pellet placement. In previous
studies we have shown that at five days post-OVX, estradiol levels were undetectable in
mice (Cheng et al., 2007; McAsey et al., 2006). The animals were randomly assigned to
either replacement with a pellet containing estradiol (0.36 mg, 60 day release, Innovative
Research of America, Sarasota, FL) or a pellet containing only the binder (vehicle).
Estradiol- or vehicle-pellets were placed subcutaneously using a trochar at the mid-scapular
level. Preliminary results from our laboratory, and published results from several
laboratories, have demonstrated that the estradiol pellets maintain 17 β-estradiol at a
constant proestrus level for at least 60 days (Cheng et al., 2007; Katovich and O’Meara,
1987; McAsey et al., 2006; Rosenblum et al., 1985).
4.3. Tissue preparation
Mice were sacrificed three days following implantation of estradiol- or vehicle-pellets. Mice
received an intraperitoneal injection of BrdU (50 mg/kg) (Sigma Aldrich, St. Louis, MO) 12
hours prior to sacrifice. For fluorescence immunohistochemistry, mice were anesthetized as
described above and transcardially perfused with cold saline (0.9% NaCl), followed by 4%
paraformaldehyde in 0.1M PBS. Olfactory turbinates were removed and cryoprotected
overnight in 30% sucrose in 0.1 M PBS. After cryoprotection, the turbinates were frozen
with dry ice and sections were cut on a cryostat at 18 μm, and air dried for 2 h at room
temperature.
4.4. CV Staining
Sections were rinsed in distilled water for 10 minutes and placed in the oven for 2 hours at
37°C. The sections were then defatted with xylene for 30 minutes. The sections were
hydrated in a series of ethanol (100%, 95%, and 70%) for 10 minutes each. Sections were
rinsed in water and stained in cresyl violet acetate solution (Sigma, St. Louis, MO) for 4
minutes. Sections were rinsed in water and in a series of ethanol (70, 95, and 100%).
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Following incubation in xylene for 30 minutes, sections were coverslipped using permount
(Fisher Scientific, Fair Lawn, NJ).
4.5. Immunohistochemical Analysis
Sections on slides were rinsed in 0.1 M PBS, and permeabilized with 0.2 % Triton X-100
(Sigma, St. Louis, MO) in PBS for 30 minutes at room temperature. The slides were rinsed
once with PBS and treated with 70, 90, 100, 90, and 70% ethanol for two minutes each (Jang
et al., 2003). Non-specific immunoreactivity was attenuated by incubation in 2.25% gelatin
in 0.1 M PBS for 1 h, followed by overnight incubation with primary antisera solution at 4
°C (see Table 1 for source and concentration used). The sections were washed three times in
PBS, and incubated for 1 hour at room temperature with secondary antibody solution as
listed in Table 1. The sections were washed three times in PBS, mounted in Vectashield
(Vector labs, Burlingame, CA). For apoE staining, KO mice were processed in parallel with
WT mice. Specificity was determined by incubation with normal serum in place of the
primary antisera which resulted in no staining.
Stained sections were examined using an Olympus BX-50 microscope. Images were
captured using a Pixera Digital Camera (Pixera, Los Gatos, CA) and saved as high
resolution TIF files. Figures from images were assembled using Photoshop (Adobe, San
Jose, CA). Image analysis was performed using Scion Image software (Scion Image,
Frederick, MD).
Morphological thickness of the OE was determined from image calibration of a stage
micrometer in Scion Image. Thickness was repeatedly measured from the horizontal basal
cell layer to the head of the sustentacular cells. The number of OMP+ in ten 100 μm
segments of OE and BrdU+ cells in 1 mm of OE was counted utilizing Scion Image. GFAP+
processes were counted by placing a 5×5 grid box over the digital image, and astrocyte
processes were marked with a dot if they crossed the grid (Struble et al., 2006). Syn
quantification was performed as described (Nwosu et al., 2008).
4.6. Statistical Analysis
All quantification procedures were performed using three mice per genotype (WT, KO) and
three mice per treatment (estrogen, vehicle). A total of 10 measurements were taken from
each animal. The data in individual experiments were presented as mean ± standard error
and statistical analysis (ANOVA, Repeated Measures ANOVA) was performed using
SYSTAT. A blinded procedure was employed in all experiments so the experimenter was
unaware of the genotype (WT versus KO) and treatment (estradiol versus vehicle) received
by the animals.
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Abbreviations
apoE apolipoprotein E
OB olfactory bulb
OE olfactory epithelium
OSN olfactory sensory neuron
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GBC globose basal cells
Sus Sustentacular cells
OMP olfactory marker protein
GFAP glial fibrillary acidic protein
Syn synaptophysin
BrdU bromodeoxyuridine
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Fig. 1.
Effects of estradiol on apoE expression in adult mouse olfactory epithelium. ApoE
immunoreactivity in ovariectomized WT mice implanted for 3 days with either a vehicle (A)
or estradiol pellet (B). Sus, sustentacular cells, OSN, olfactory sensory neuron, BC, basal
cell zone, BV, blood vessel, OF olfactory fascicle. Arrow indicates basal lamina. ApoE
immunoreactivity in vehicle- and estradiol-treated mice was intense in the perikarya of the
sustentacular cells and was faint around the OSN. Intense apoE staining above the basal
lamina was present in oblong cells (arrow heads) in the vehicle group, and in punctas
surrounding globose cells in the estradiol treated group (asterisks). Endothelial cells of the
blood vessels in both treatment groups were strongly stained. ApoE immunostaining was
present throughout the core of the olfactory fascicle in estradiol treated mice, and was very
faint in the vehicle treated mice. Scale bars = 10 μm.
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Fig. 2.
ApoE immunostaining in the olfactory nerve and glomerular layer of the OB of
ovariectomized WT mice implanted with either vehicle (A) or estradiol (B) pellet. ApoE
immunostaining was weak throughout the OB in the vehicle-treated mice. In the estradiol-
treated mice, dense apoE immunoreactivity was observed in cellular processes (arrows) in
the olfactory nerve fascicles and in cells surrounding the glomeruli (arrow heads). Scale bars
= 10 μm.
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Fig. 3.
GFAP immunoreactivity in the glomerular layer of the OB. Estradiol treatment increased
GFAP immunoreactive processes in WT (B) and KO (D) mice as compared to vehicle
treated WT (A) and KO (C) mice. Scale bars = 10 μm. (E) Quantification of GFAP
immunoreactive process density in vehicle (Vh) and estradiol (Es) treated WT and KO mice
(Mean and SE). Estrogen treatment significantly increased GFAP process density (*).
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Fig. 4.
Cresyl violet stained sections of OE from WT (A, B) and KO (C, D) mice implanted with an
estradiol (B, D) or a vehicle (A, C) pellet. Irrespective of the genotype, estradiol treatment
increased OE thickness. Scale bars = 10 μm. (E) Quantification of OE thickness in WT and
KO mice treated with estradiol (Es) or vehicle (Vh) (Mean and SE). Estrogen treatment
significantly increased OE thickness (*).
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Fig. 5.
BrdU staining in the basal cell zone of OE. Estradiol treatment increased BrdU
immunoreactive cells in WT (B) and KO (D) mice as compared to vehicle treated WT (A)
and KO (C) mice. Scale bars = 10 μm. (E) Quantification of BrdU+ cells in vehicle (Vh) and
estradiol (Es) treated WT and KO mice (Mean and SE).
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Fig. 6.
OMP stained sections of OE from WT (A, B) and KO (C, D) mice implanted with an
estradiol (B, D) or a vehicle (A, C) pellet. Irrespective of the genotype, estradiol treatment
increased OMP+ cells; however, estradiol-treated WT mice had about 20% more OMP
labeled cells than the estradiol-treated KO mice. Scale bars = 10 μm. (E) Quantification of
OMP+ cells in WT and KO mice treated with estradiol (Es) or vehicle (Vh) (Mean and SE).
Estrogen treatment significantly increased OMP+ cells (*).
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Fig. 7.
OMP staining in the glomerular layer of the OB in WT (A, B) and KO (C, D) mice
implanted with an estradiol (B, D) or a vehicle (A, C) pellet. Estradiol increased OMP
staining in both the genotypes, but the effect was more pronounced in the estradiol-treated
WT as compared to estradiol-treated KO. Scale bars = 10 μm.
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Fig. 8.
Syn staining in the glomerular layer of the OB. Estradiol treatment increased Syn staining in
WT (B) and KO (D) mice as compared to vehicle treated WT (A) and KO (C) mice.
However, the magnitude of increase was significantly greater in the WT than in the KO.
Scale bars = 10 μm. (E) Densitometric quantification of Syn density in vehicle (Vh) and
estradiol (Es) treated WT and KO mice. Estrogen treatment significantly increased Syn
density (*).
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Table 1
List of primary and secondary antibodies used in this study
Antibodies Host Source Dilution
ApoE Goat Calbiochem, San Diego, CA 1:1000
OMP Goat Wako, Richmond, VA 1:500
Syn Rabbit Cell Marque, Rocklin, CA 1:500
BrdU Rat Accurate, Westbury, NY 1:500
GFAP Mouse Accurate, Westbury, NY 1:500
FITC-anti goat Donkey Jackson, West Grove, PA 1:500
Cy3-anti goat Donkey Jackson, West Grove, PA 1:500
Cy3-anti rat Goat Jackson, West Grove, PA 1:500
Alexa-anti rabbit Donkey Invitrogen, Eugene, OR 1:200
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